CN106404953B - 一种青霉素皮试冻干粉剂的质量检测方法 - Google Patents
一种青霉素皮试冻干粉剂的质量检测方法 Download PDFInfo
- Publication number
- CN106404953B CN106404953B CN201610797234.2A CN201610797234A CN106404953B CN 106404953 B CN106404953 B CN 106404953B CN 201610797234 A CN201610797234 A CN 201610797234A CN 106404953 B CN106404953 B CN 106404953B
- Authority
- CN
- China
- Prior art keywords
- dried powder
- freeze dried
- skin test
- follows
- penicillin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 88
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 title claims abstract description 70
- 229930182555 Penicillin Natural products 0.000 title claims abstract description 56
- 239000000843 powder Substances 0.000 title claims abstract description 53
- 229940049954 penicillin Drugs 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 45
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000000243 solution Substances 0.000 claims abstract description 38
- 239000012085 test solution Substances 0.000 claims abstract description 36
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 claims abstract description 31
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 13
- 239000011521 glass Substances 0.000 claims abstract description 10
- 239000000706 filtrate Substances 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 39
- 238000001514 detection method Methods 0.000 claims description 36
- 239000013558 reference substance Substances 0.000 claims description 29
- 238000002360 preparation method Methods 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 11
- 238000010829 isocratic elution Methods 0.000 claims description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 230000005526 G1 to G0 transition Effects 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 7
- 238000003908 quality control method Methods 0.000 abstract description 4
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 23
- 239000007924 injection Substances 0.000 description 19
- 238000002347 injection Methods 0.000 description 19
- 229940079593 drug Drugs 0.000 description 15
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 229940056360 penicillin g Drugs 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 235000019371 penicillin G benzathine Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000012535 impurity Substances 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 150000002960 penicillins Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000012372 quality testing Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WXYIONYJZVWSIJ-UHFFFAOYSA-N acetonitrile;methanol;hydrate Chemical group O.OC.CC#N WXYIONYJZVWSIJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002052 anaphylactic effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000000711 polarimetry Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- OPEGYZAATHKDEM-HCWXCVPCSA-N (2r,4s)-2-[(r)-carboxy(formamido)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid Chemical compound CC1(C)S[C@H]([C@H](NC=O)C(O)=O)N[C@H]1C(O)=O OPEGYZAATHKDEM-HCWXCVPCSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- IJVLVRYLIMQVDD-UHFFFAOYSA-N 1,3-thiazole-2-carboxylic acid Chemical class OC(=O)C1=NC=CS1 IJVLVRYLIMQVDD-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 229960001931 ampicillin sodium Drugs 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 1
- FWRNIJIOFYDBES-ZQDFAFASSA-L disodium;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[[(2r)-2-phenyl-2-sulfonatoacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Na+].[Na+].C1([C@H](C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)S([O-])(=O)=O)=CC=CC=C1 FWRNIJIOFYDBES-ZQDFAFASSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940124585 oral penicillin Drugs 0.000 description 1
- VDUVBBMAXXHEQP-SLINCCQESA-M oxacillin sodium Chemical compound [Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 VDUVBBMAXXHEQP-SLINCCQESA-M 0.000 description 1
- 201000005354 penicillin allergy Diseases 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- QGPGUZIKJKOKRF-UHFFFAOYSA-M potassium;acetonitrile;dihydrogen phosphate Chemical compound [K+].CC#N.OP(O)([O-])=O QGPGUZIKJKOKRF-UHFFFAOYSA-M 0.000 description 1
- NHOXRBDMOTVJBL-UHFFFAOYSA-M potassium;dihydrogen phosphate;methanol Chemical compound [K+].OC.OP(O)([O-])=O NHOXRBDMOTVJBL-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
序号 | 名称 | 出峰时间(min) | 回收率(%) | RSD(%) |
1# | Nova pak C<sub>18</sub>柱 | 4.58 | 99.8 | 1.1 |
2# | Eclipse OB C<sub>8</sub>柱 | 3.48 | 98.7 | 1.5 |
3# | Agilent Tc C<sub>18</sub>柱 | 3.15 | 95.6 | 0.9 |
成分(%) | Nova-pak C<sub>18</sub>柱 | Eclipse OB C<sub>8</sub>柱 | Agilent Tc C<sub>18</sub>柱 |
对照品 | 99.1 | 92.5 | 87.4 |
青霉素钠 | 96.4 | 94.3 | 80.9 |
乳糖 | 2.6 | 3.1 | 0.12 |
甘露醇 | 1.4 | 2.2 | 0.44 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610797234.2A CN106404953B (zh) | 2016-08-31 | 2016-08-31 | 一种青霉素皮试冻干粉剂的质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610797234.2A CN106404953B (zh) | 2016-08-31 | 2016-08-31 | 一种青霉素皮试冻干粉剂的质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106404953A CN106404953A (zh) | 2017-02-15 |
CN106404953B true CN106404953B (zh) | 2019-02-15 |
Family
ID=58001872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610797234.2A Active CN106404953B (zh) | 2016-08-31 | 2016-08-31 | 一种青霉素皮试冻干粉剂的质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106404953B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112763591A (zh) * | 2020-12-15 | 2021-05-07 | 上海明捷医药科技有限公司 | 一种测定蛋白溶液中青霉素含量的方法 |
CN115266967A (zh) * | 2022-07-11 | 2022-11-01 | 瑞阳制药股份有限公司 | 青霉素钠有关物质的超高效液相色谱法测定方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5991365A (ja) * | 1982-11-17 | 1984-05-26 | Toyo Soda Mfg Co Ltd | 液体クロマトグラフ用溶離液組成物 |
CN103336083A (zh) * | 2013-06-19 | 2013-10-02 | 哈尔滨工业大学 | 一种青霉素菌渣中青霉素g的高效液相色谱检测方法 |
CN104483427A (zh) * | 2014-12-08 | 2015-04-01 | 华东理工大学 | 一种分离富集并同时检测饮用水源水中12种抗生素的方法 |
CN105628808A (zh) * | 2015-12-25 | 2016-06-01 | 光明乳业股份有限公司 | 预处理方法及阿莫西林、青霉素g和青霉素v的检测方法 |
-
2016
- 2016-08-31 CN CN201610797234.2A patent/CN106404953B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5991365A (ja) * | 1982-11-17 | 1984-05-26 | Toyo Soda Mfg Co Ltd | 液体クロマトグラフ用溶離液組成物 |
CN103336083A (zh) * | 2013-06-19 | 2013-10-02 | 哈尔滨工业大学 | 一种青霉素菌渣中青霉素g的高效液相色谱检测方法 |
CN104483427A (zh) * | 2014-12-08 | 2015-04-01 | 华东理工大学 | 一种分离富集并同时检测饮用水源水中12种抗生素的方法 |
CN105628808A (zh) * | 2015-12-25 | 2016-06-01 | 光明乳业股份有限公司 | 预处理方法及阿莫西林、青霉素g和青霉素v的检测方法 |
Non-Patent Citations (3)
Title |
---|
Separation and Determination of Five Penicillins by Reversed Phase HPLC;I. P. Kaniou et al;《Journal of Liquid Chromatography & Related Technologies》;19931231;第16卷(第13期);2891-2897 |
The Analysis of Penicillins in Biological Fluids and Pharmaceutical Preparations by High Performance Liquid Chromatography: A Review;John O. Miners;《Journal of Liquid Chromatography》;19851231;第8卷(第15期);2827-2843 |
马珊珊 等.加速溶剂萃取(ASE)⁃固相萃取(SPE)⁃高效液相色谱法(HPLC)测定土壤中青霉素钠.《环境化学》.2014,第33卷(第11期), |
Also Published As
Publication number | Publication date |
---|---|
CN106404953A (zh) | 2017-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103344733B (zh) | 一种硼替佐米对映异构体的高效液相色谱分离检测方法 | |
CN110146621B (zh) | 头孢类抗生素药物中聚合物的含量测定方法 | |
CN106404953B (zh) | 一种青霉素皮试冻干粉剂的质量检测方法 | |
CN105085570A (zh) | 一种磷酸特地唑胺化合物及其制备方法 | |
Shah et al. | Development and validation of HPLC method for simultaneous determination of ceftriaxone and cefaclor in commercial formulations and biological samples | |
CN104644578A (zh) | 磷酸西格列汀组合物片剂及其制备方法 | |
CN104546851A (zh) | 一种颗粒组合物及其制备方法、制剂 | |
CN102342910B (zh) | 一种盐酸左氧氟沙星注射液药物组合物及制备方法 | |
Garcia-Martínez et al. | Bionalytical validation study for the determination of unbound ambrisentan in human plasma using rapid equilibrium dialysis followed by ultra performance liquid chromatography coupled to mass spectrometry | |
CN102846704B (zh) | 一种益母草注射液、其制备方法和总生物碱的检测方法 | |
WO2009155755A1 (zh) | 巴戟天寡糖的含量测定方法 | |
CN104597157B (zh) | 一种脂溶性铂配合物及其制剂有关物质的测定方法 | |
CN106706835A (zh) | 一种金莲花泡腾片的质量检测方法 | |
CN106525994A (zh) | 一种氨酚曲马多胶囊有关物质的测定方法 | |
CN114965754A (zh) | 对乙酰氨基酚片中有关物质及抑菌剂的检测方法 | |
CN103816126B (zh) | 一种含有丁溴东莨菪碱的药物组合物 | |
CN102552210B (zh) | 一种恩替卡韦胶囊组合物及其制备方法 | |
CN107449844B (zh) | 一种测定二巯丁二酸制剂溶出度的方法 | |
CN108398493B (zh) | 一种积雪草药材及其提取物与制剂的质量检测方法 | |
CN111707766A (zh) | 一种琥珀酸呋罗曲坦片的检测方法 | |
CN103462907A (zh) | 一种注射用奥美拉唑钠冻干粉针剂及其制备方法 | |
CN105596307B (zh) | 一种茴拉西坦片剂的制备方法 | |
Foppa et al. | Development, validation and stability study of pediatric atenolol syrup | |
CN107860829B (zh) | 一种蒲桃益胃颗粒的质量控制方法 | |
MARELLA et al. | A NOVEL AND ROBUST ANALYTICAL TECHNIQUE FOR DETERMINING COVID-19 MEDICATIONS USED IN EMERGENCIES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240514 Address after: 702, Building 7, Xixi United Technology Plaza, No. 970-1 Gaojiao Road, Wuchang Street, Yuhang District, Hangzhou City, Zhejiang Province, 310023 Patentee after: Zhejiang Langxu Pharmaceutical Co.,Ltd. Country or region after: China Address before: No. 81 Zhubuli, Xiacheng District, Hangzhou City, Zhejiang Province, 310012 Patentee before: Zhang Zhulin Country or region before: China |
|
TR01 | Transfer of patent right |
Effective date of registration: 20241012 Address after: Sanlitang, Qianyuan Town, Deqing County, Huzhou City, Zhejiang Province 313216 Patentee after: ZHEJIANG ZHEBEI PHARMACEUTICAL CO.,LTD. Country or region after: China Patentee after: Zhejiang Langxu Pharmaceutical Co.,Ltd. Address before: 702, Building 7, Xixi United Technology Plaza, No. 970-1 Gaojiao Road, Wuchang Street, Yuhang District, Hangzhou City, Zhejiang Province, 310023 Patentee before: Zhejiang Langxu Pharmaceutical Co.,Ltd. Country or region before: China |